Episode

Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab

Podcast
The IMID Forum
Published
Dec 11, 2025
Duration seconds
788
Processing state
not_requested
Canonical source
https://soundcloud.com/imidforum/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab
Audio
https://feeds.soundcloud.com/stream/2227763981-imidforum-discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab.mp3
JSON
/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab
Markdown
/podcast/the-imid-forum-981476/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered a retrospective, multinational, cross-sectional survey of real-world outcomes for patients with axial spondyloarthritis receiving subcutaneous infliximab